Off-label Drug Use in Hospitalized Children: A Systematic Review

ZHANG Ling-li,LI You-ping,LIANG Yi,ZENG Li-nan,LIU Yi,CHEN Min

DOI: https://doi.org/10.3969/j.issn.1672-2531.2012.02.010

2012-01-01

Abstract:Objective To assess the global situation of off-label drug use in hospitalized children.Methods The databases such as PubMed,EMbase,CBM,CNKI and VIP were searched to collect studies on off-label drug use in hospitalized children at age of 0 to 18 years old.The publication language was limited to English and Chinese.The quality assessment was based on Crombie Criteria for cross-sectional studies.The incidence of off-label drug use was described in different wards and age groups,and the proportion of different off-label used drugs was analyzed.Results The total 29 cross-sectional studies were included,involving 8?560 children and 41?655 prescriptions.a) Median(IQR) of off-label use incidence: Neonatal ICU 52.5%(23.0% to 44.8%),Pediatric ICU 43.5%(34.5% to 60%),General pediatric ward 35.5%(23.8% to 43.3%),Pediatric surgical ward 27.5%(23.0% to 44.8%);b) The results of off-label incidence in different age groups were inconsistent among different studies;and c) The off-label drug use for pediatric had the largest proportion,followed by dose and age.Conclusion a) Off-label drug use exists widely around the world,but the incidence varies a lot in different countries and different types of wards;b) The incidence of off-label drug use may be higher in ICU than in non-ICU,and higher in the neonatal ward than the pediatric ward;c) The off-label drug use for no pediatric information is the commonest type,and further clinical studies should focus on areas in which high quality evidence is totally absent;and d) The multi-center studies with unified design on off-label drug use in hospitalized children in China are urgently needed to provide evidence for policy-making.